(Reuters) -Johnson & Johnson (JNJ) committed to invest $2 billion in North Carolina on Thursday to expand the drugmaker's U.S. manufacturing presence as potential drug import duties from President Donald Trump's administration loom.

J&J said it plans to build a new facility at Tokyo-based Fujifilm Diosynth's manufacturing site in Holly Springs, North Carolina, over the next 10 years.

The expansion would create about 120 new jobs, the drugmaker said.

(Reporting by Mariam Sunny in Bengaluru; Editing by Rashmi Aich)